PDS Biotechnology Corporation
PDSB
$0.82
$0.056.44%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.50% | -11.13% | -6.75% | 25.86% | -28.80% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -127.58% | 308.66% | -8.46% | -2.39% | 7.51% |
| Total Other Non-Cash Items | 346.27% | -69.26% | -11.36% | -7.54% | -13.79% |
| Change in Net Operating Assets | 211.41% | 45.63% | -2.20% | -456.33% | 121.73% |
| Cash from Operations | 35.00% | -0.76% | -9.69% | -2.93% | 9.69% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 94.85% | -527.51% | -0.01% | -22,165.25% | -2.17% |
| Issuance of Common Stock | -13.97% | -79.99% | 120.41% | 10,482.11% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | -75.78% | -86.40% | 4,136.86% | 904.65% | 224.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.99% | -373.74% | 78.78% | -0.99% | 10.32% |